Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DAWN
4051
DELISTED
Day One Biopharmaceuticals
DAWN
| $3.84M | ﹤0.01% |
232,550
-436,328
| -65% | -$6.53M |
|
4052
Metropolitan Bank Holding Corp
MCB
$1.15B
| $3.84M | ﹤0.01% |
99,618
-117,844
| -54% | -$5.16M |
|
|
GBIO
4053
DELISTED
Generation Bio
GBIO
| $3.83M | ﹤0.01% |
94,178
-118,635
| -56% | -$2.79M |
|
|
XOMA
4054
DELISTED
Xoma
XOMA
| $3.83M | ﹤0.01% |
159,183
+128,089
| +412% | +$2.87M |
|
|
OLK
4055
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $3.83M | ﹤0.01% |
162,819
+127,851
| +366% | +$3.08M |
|
4056
ALX Oncology
ALXO
$290M
| $3.83M | ﹤0.01% |
343,137
-484,449
| -59% | -$6.8M |
|
|
HPI
4057
John Hancock Preferred Income Fund
HPI
$433M
| $3.83M | ﹤0.01% |
230,058
-738,606
| -76% | -$11.9M |
|
4058
TaskUs
TASK
$669M
| $3.82M | ﹤0.01% |
327,864
-528,044
| -62% | -$6.6M |
|
4059
Xponential Fitness
XPOF
$211M
| $3.82M | ﹤0.01% |
230,866
-568,372
| -71% | -$6.99M |
|
4060
Park Aerospace
PKE
$819M
| $3.82M | ﹤0.01% |
229,593
-257,777
| -53% | -$3.83M |
|
4061
Cerus
CERS
$474M
| $3.8M | ﹤0.01% |
2,012,432
-788,200
| -28% | -$1.61M |
|
|
IOBT
4062
DELISTED
IO Biotech
IOBT
| $3.8M | ﹤0.01% |
2,197,234
-2,366,130
| -52% | -$4.11M |
|
4063
WisdomTree US Multifactor Fund
USMF
$303M
| $3.8M | ﹤0.01% |
81,618
+57,350
| +236% | +$2.53M |
|
4064
Peoples Bancorp
PEBO
$1.47B
| $3.79M | ﹤0.01% |
128,021
-323,339
| -72% | -$9.49M |
|
4065
Triple Flag Precious Metals
TFPM
$6.72B
| $3.79M | ﹤0.01% |
262,275
-250,881
| -49% | -$3.24M |
|
4066
Invesco Bond Fund
VBF
$169M
| $3.79M | ﹤0.01% |
242,048
-221,386
| -48% | -$3.47M |
|
4067
State Street SPDR S&P Global Dividend ETF
WDIV
$281M
| $3.78M | ﹤0.01% |
63,084
-59,102
| -48% | -$3.5M |
|
|
MVF
4068
DELISTED
BlackRock MuniVest Fund
MVF
| $3.77M | ﹤0.01% |
533,955
-382,995
| -42% | -$2.68M |
|
4069
Vermilion Energy
VET
$1.66B
| $3.76M | ﹤0.01% |
302,377
-1,340,321
| -82% | -$15M |
|
4070
Theravance Biopharma
TBPH
$877M
| $3.76M | ﹤0.01% |
419,113
-107,785
| -20% | -$999K |
|
4071
ProShares Short Russell2000
RWM
$129M
| $3.75M | ﹤0.01% |
186,903
-727,401
| -80% | -$15.5M |
|
4072
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$4.05B
| $3.75M | ﹤0.01% |
271,029
+184,305
| +213% | +$1.79M |
|
|
MIN
4073
Aberdeen Intermediate Income Fund
MIN
$278M
| $3.74M | ﹤0.01% |
1,407,614
-1,433,398
| -50% | -$3.91M |
|
4074
iShares MSCI Malaysia ETF
EWM
$325M
| $3.74M | ﹤0.01% |
171,579
-166,505
| -49% | -$3.58M |
|
|
THTX
4075
DELISTED
Theratechnologies
THTX
| $3.74M | ﹤0.01% |
2,252,232
-2,266,568
| -50% | -$3.64M |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 332 positions and reducing 6,745 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 332 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.